title: The use of OKT3 in combined pancreas-kidney allotransplantation.
authors.affiliation: University of Wisconsin School of Medicine, Madison.
authors.forename: J S
authors.initials: JS
authors.lastname: Melzer
authors.forename: A M
authors.initials: AM
authors.lastname: D'Alessandro
authors.forename: M
authors.initials: M
authors.lastname: Kalayoglu
authors.forename: J D
authors.initials: JD
authors.lastname: Pirsch
authors.forename: F O
authors.initials: FO
authors.lastname: Belzer
authors.forename: H W
authors.initials: HW
authors.lastname: Sollinger
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum